November 17 FDA Meeting Could Define the Next Phase for NEO212 Dallas, Texas (www.InvestorsTape.com) — NeOnc Technologies Holdings (NASDAQ: NTHI) is heading toward another potentially important regulatory milestone, with the U.S. Food and Drug Administration scheduled to meet with the company on November 17, 2026, for an in-person End-of-Phase 1 Type B meeting concerning NEO212,…
Dallas, Texas (www.InvestorsTape.com) — The Chief Executive Officer of NeOnc Technologies Holdings (NASDAQ:NTHI), Amir F. Heshmatpour has purchased another 37,000 shares of the company’s common stock, adding to his investment following NeOnc’s announcement of a $15 million financing with healthcare-focused institutional investors. A September 14 Form 4 shows that Heshmatpour acquired shares on September 11…
